A comparison of iPLEDGE requirements to risk mitigation programs for isotretinoin in other countries and to other teratogenic medications in the United States

Authors

Nikita Menta, The George Washington University School of Medicine and Health Sciences, Washington, DC 20052.
Nidhi Shah, The George Washington University School of Medicine and Health Sciences, Department of Dermatology, Washington, DC 20052.
A Yasmine Kirkorian, The George Washington University School of Medicine and Health Sciences, Department of Dermatology, Washington, DC 20052; Children's National Hospital, Division of Dermatology, Washington, DC 20010.

Document Type

Journal Article

Publication Date

1-15-2025

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2024.12.039

Keywords

iPLEDGE; isotretinoin; pregnancy prevention programs; risk evaluation and mitigation strategies; teratogen

APA Citation

Menta, Nikita; Shah, Nidhi; and Kirkorian, A Yasmine, "A comparison of iPLEDGE requirements to risk mitigation programs for isotretinoin in other countries and to other teratogenic medications in the United States" (2025). GW Authored Works. Paper 6356.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/6356

Department

School of Medicine and Health Sciences Student Works